Avacta Group plc
Admission of Supplementary Consideration Shares
Further to the announcement of 8 August 2006, Avacta Group plc ("Avacta" or the
"Company") is pleased to announce the acquisition of the Avacta Option Shares
issued upon the exercise of the Avacta Options pursuant to the Supplemental
Acquisition Agreement.
The consideration for the Avacta Option Shares has been satisfied by the
allotment and issue of 24,469,898 new Ordinary Shares of the Company which have
been admitted to trading on AIM today. The new Ordinary Shares represent
approximately 3.66% of the enlarged issued share capital of the Company which
now totals 669,327,344 Ordinary Shares.
Following Admission, Daron Lee no longer has a notifiable interest in the
Company and the interests of certain directors are as follows:
Director Number of Ordinary Shares Percentage of Enlarged
Share Capital
Professor Alastair Smith 49,217,468 7.35
Simon Webster 48,624,258 7.26
Kurt Baldwin 48,624,258 7.26
All terms used in this announcement are defined as set out in the Admission
Document dated 13 July 2006.
9 August 2006
Enquiries:
Avacta Group plc Tel: 0870 835 4367
Alastair Smith, Chief Executive
WH Ireland Limited Tel: 0161 832 2174
David Youngman, Director, Corporate Finance
Nexus Financial Ltd Tel: 020 7451 7050
Nicholas Nelson, Director nicholas.nelson@nexusgroup.co.uk
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.